| Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer T Shree, OC Olson, BT Elie, JC Kester, AL Garfall, K Simpson, ... Genes & development 25 (23), 2465-2479, 2011 | 592 | 2011 |
| Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer G Iyer, H Al-Ahmadie, N Schultz, AJ Hanrahan, I Ostrovnaya, AV Balar, ... Journal of Clinical Oncology 31 (25), 3133-3140, 2013 | 332 | 2013 |
| Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis JM Scott, EC Zabor, E Schwitzer, GJ Koelwyn, SC Adams, TS Nilsen, ... Journal of Clinical Oncology 36 (22), 2297-2305, 2018 | 295 | 2018 |
| An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma AA Hakimi, H Furberg, EC Zabor, A Jacobsen, N Schultz, G Ciriello, ... Journal of the National Cancer Institute 105 (24), 1862-1870, 2013 | 285 | 2013 |
| Guidelines for reporting of statistics for clinical research in urology M Assel, D Sjoberg, A Elders, X Wang, D Huo, A Botchway, K Delfino, ... The Journal of urology 201 (3), 595-604, 2019 | 274 | 2019 |
| DNA damage response and repair gene alterations are associated with improved survival in patients with platinum-treated advanced urothelial carcinoma MY Teo, RM Bambury, EC Zabor, E Jordan, H Al-Ahmadie, ME Boyd, ... Clinical cancer research 23 (14), 3610-3618, 2017 | 249 | 2017 |
| Genomic characterization of upper tract urothelial carcinoma JP Sfakianos, EK Cha, G Iyer, SN Scott, EC Zabor, RH Shah, Q Ren, ... European urology 68 (6), 970-977, 2015 | 239 | 2015 |
| Body mass index and metastatic renal cell carcinoma: clinical and biological correlations L Albiges, AA Hakimi, W Xie, RR McKay, R Simantov, X Lin, JL Lee, ... Journal of Clinical Oncology 34 (30), 3655-3663, 2016 | 219 | 2016 |
| Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer HA Al-Ahmadie, G Iyer, BH Lee, SN Scott, R Mehra, A Bagrodia, ... Nature genetics 48 (4), 356-358, 2016 | 183 | 2016 |
| A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma K Kadota, K Suzuki, SS Kachala, EC Zabor, CS Sima, AL Moreira, ... Modern pathology 25 (8), 1117-1127, 2012 | 176 | 2012 |
| Intra-arterial chemotherapy for retinoblastoma in eyes with vitreous and/or subretinal seeding: 2-year results DH Abramson, BP Marr, IJ Dunkel, S Brodie, EC Zabor, SJ Driscoll, ... British journal of ophthalmology 96 (4), 499-502, 2012 | 172 | 2012 |
| Genetic determinants of cisplatin resistance in patients with advanced germ cell tumors A Bagrodia, BH Lee, W Lee, EK Cha, JP Sfakianos, G Iyer, EJ Pietzak, ... Journal of Clinical Oncology 34 (33), 4000-4007, 2016 | 165 | 2016 |
| Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder PH Kim, EK Cha, JP Sfakianos, G Iyer, EC Zabor, SN Scott, I Ostrovnaya, ... European urology 67 (2), 198-201, 2015 | 163 | 2015 |
| Impact of smoking and smoking cessation on oncologic outcomes in primary non–muscle-invasive bladder cancer M Rink, H Furberg, EC Zabor, E Xylinas, M Babjuk, A Pycha, Y Lotan, ... European urology 63 (4), 724-732, 2013 | 146 | 2013 |
| Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection? TA Moo, M Edelweiss, S Hajiyeva, M Stempel, M Raiss, EC Zabor, ... Annals of surgical oncology 25, 1488-1494, 2018 | 136 | 2018 |
| Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy EJ Pietzak, EC Zabor, A Bagrodia, J Armenia, W Hu, A Zehir, S Funt, ... European urology 75 (2), 231-239, 2019 | 128 | 2019 |
| Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy M Rink, EC Zabor, H Furberg, E Xylinas, B Ehdaie, G Novara, M Babjuk, ... European urology 64 (3), 456-464, 2013 | 125 | 2013 |
| Myxofibrosarcoma: prevalence and diagnostic value of the “tail sign” on magnetic resonance imaging RA Lefkowitz, J Landa, S Hwang, EC Zabor, CS Moskowitz, NP Agaram, ... Skeletal radiology 42, 809-818, 2013 | 123 | 2013 |
| Randomized controlled trials EC Zabor, AM Kaizer, BP Hobbs Chest 158 (1), S79-S87, 2020 | 121 | 2020 |
| Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma J Casuscelli, N Weinhold, G Gundem, L Wang, EC Zabor, E Drill, PI Wang, ... JCI insight 2 (12), 2017 | 119 | 2017 |
